» Articles » PMID: 36959952

Oncofertility Research Pitfall? Recall Bias in Young Adult Cancer Survivors

Overview
Journal F S Rep
Date 2023 Mar 24
PMID 36959952
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess recall bias by evaluating how well female cancer survivors remember details regarding their cancer diagnosis, treatment, and fertility preservation (FP) counseling.Oncofertility literature cites recall bias as a pitfall of retrospective surveys, but limited data exist to quantify this bias.

Design: Retrospective secondary analysis of cross-sectional survey data.

Setting: Single academic medical center.

Patients: Female oncology patients of reproductive age, 18-44 years old, at least 6 months past their last chemotherapy treatment.

Interventions: Not applicable.

Main Outcome Measures: Recall of details surrounding cancer diagnosis and chemotherapy regimens, recall of FP counseling and ovarian reserve testing, and rates of chart-documented FP counseling.

Results: In total, 117 patients completed the survey, with 112 verified via chart review. When asked to report the chemotherapy regimen, 57% (64 of the 112) marked "I don't know/prefer not to say." Regarding FP, 80% (90 of the 112) denied being offered counseling. Of the 37 (33%) who had documented FP conversations, 13 (35%) did not recall mention of fertility. Only 2 of 8 patients with ovarian reserve testing recalled this being performed at their initial visit. Multivariable logistic regression revealed older age was significantly associated with not being offered FP (odds ratio [OR] 0.87).

Conclusions: Our results confirm that the accuracy of oncology patients' reporting is limited by a poor recall, particularly regarding their specific chemotherapy regimen. More than 1 in 3 patients documented to have been offered FP counseling do not recall this discussion. Importantly, only one-third of cancer survivors had chart-documented FP counseling. Increased efforts are needed to ensure adequate follow-up beyond the initial visit.

Citing Articles

Counseling and cryopreservation: evaluation of patient-reported counseling and choice on method of cancer-related fertility preservation.

Pecoriello J, Quinn G, Hade E, Reinecke J J Assist Reprod Genet. 2024; 41(10):2807-2812.

PMID: 39083108 PMC: 11535109. DOI: 10.1007/s10815-024-03217-3.


Reproductive Health Assessment and Reports of Fertility Counseling in Pediatric and Adolescent Patients with Sickle Cell Disease After Hematopoietic Cell Transplantation.

George S, Veludhandi A, Xiang Y, Liu K, Stenger E, Arnold S Transplant Cell Ther. 2024; 30(9):912.e1-912.e13.

PMID: 38972510 PMC: 11344653. DOI: 10.1016/j.jtct.2024.06.029.

References
1.
Goldman R, Racowsky C, Farland L, Munne S, Ribustello L, Fox J . Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients. Hum Reprod. 2017; 32(4):853-859. DOI: 10.1093/humrep/dex008. View

2.
Moravek M, Appiah L, Anazodo A, Burns K, Gomez-Lobo V, Hoefgen H . Development of a Pediatric Fertility Preservation Program: A Report From the Pediatric Initiative Network of the Oncofertility Consortium. J Adolesc Health. 2019; 64(5):563-573. PMC: 6478520. DOI: 10.1016/j.jadohealth.2018.10.297. View

3.
Shnorhavorian M, Harlan L, Smith A, Keegan T, Lynch C, Prasad P . Fertility preservation knowledge, counseling, and actions among adolescent and young adult patients with cancer: A population-based study. Cancer. 2015; 121(19):3499-506. PMC: 4734641. DOI: 10.1002/cncr.29328. View

4.
Chung E, Acharya C, Harris B, Acharya K . Development of a fertility risk calculator to predict individualized chance of ovarian failure after chemotherapy. J Assist Reprod Genet. 2021; 38(11):3047-3055. PMC: 8609057. DOI: 10.1007/s10815-021-02311-0. View

5.
Duffy C, Allen S, Dube C, Dickersin K . Oncologists' confidence in knowledge of fertility issues for young women with cancer. J Cancer Educ. 2012; 27(2):369-76. PMC: 3352969. DOI: 10.1007/s13187-011-0304-1. View